Literature DB >> 2041665

Parapneumonic empyema in children: decortication hastens recovery in patients with severe pleural infections.

S J Hoff1, W W Neblett, K M Edwards, R M Heller, J B Pietsch, G W Holcomb, G W Holcomb.   

Abstract

The medical records of 61 children 0 to 18 years of age treated for empyema complicating pneumonia from 1977 to 1989 were reviewed with attention to clinical presentation, bacteriology, treatment and outcome. Streptococcus pneumoniae was the most common infecting organism, followed by Staphylococcus aureus, other streptococcal species, anaerobes, Haemophilus influenzae type b, Pseudomonas aeruginosa, and Eikenella corrodens. No organisms were recovered in 39% of patients. Twelve patients were treated successfully with antibiotics and thoracentesis alone, 23 patients underwent close tube thoracostomy and 26 required decortication. A thickened pleural "peel," scoliosis and opacification of a hemithorax on chest radiograph, as well as low pleural pH and glucose concentration, were associated with a poor response to medical management. A scoring system was developed to define the severity of pleural disease. In patients with severe pleural infections, decortication allowed more rapid defervescence (2.2 vs. 6.5 days) and earlier hospital discharge (4.4 vs. 12.4 days) than did closed tube thoracostomy (P less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041665

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Complicated pneumonias with empyema and/or pneumatocele in children.

Authors:  Valmir Kunyoshi; Daniele Cristina Cataneo; Antônio José Maria Cataneo
Journal:  Pediatr Surg Int       Date:  2005-12-16       Impact factor: 1.827

2.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

3.  Postpneumonic empyema in childhood.

Authors:  N Belet; S Uysal; E Bernay; N Gurses
Journal:  Indian J Pediatr       Date:  2001-01       Impact factor: 1.967

4.  Puerperal fever and neonatal pleural empyema and bacteremia caused by group A streptococcus.

Authors:  L Lequier; W L Vaudry
Journal:  Can J Infect Dis       Date:  1998-05

5.  Empyema thoracis: a role for open thoracotomy and decortication.

Authors:  J A Carey; J R Hamilton; D A Spencer; K Gould; A Hasan
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

6.  The treatment of empyema in childhood.

Authors:  A Bush
Journal:  J R Soc Med       Date:  1994-05       Impact factor: 5.344

7.  Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia.

Authors:  Angela L Myers; Matthew Hall; Derek J Williams; Katherine Auger; Joel S Tieder; Angela Statile; Karen Jerardi; Lauren McClain; Samir S Shah
Journal:  Pediatr Infect Dis J       Date:  2013-07       Impact factor: 2.129

8.  Contemporary empyema thoracis necessitans in an adult male caused by Staphylococcus aureus: decortication is superior to traditional under water seal intercostal tube in chronic empyema.

Authors:  Liaqat Ali Chaudhry; Ahmed A Ba Mousa; Marwan Zamzami; Asirvatham Alwin Robert
Journal:  Pan Afr Med J       Date:  2015-02-09

9.  An intra-abdominal abscess or "rind" as a consequence of peritoneal dialysis-associated pseudomonas peritonitis.

Authors:  R Michael Culpepper; Sarah Gore; Gregory W Rutecki
Journal:  Clin Nephrol Case Stud       Date:  2013-02-26

10.  Video-assisted thoracoscopic surgery in the management of pediatric empyema.

Authors:  R R Gandhi; G Stringel
Journal:  JSLS       Date:  1997 Jul-Sep       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.